Skip to content

Investigating the effect of Zinc Supplement on mood, anxiety and quality of life in the elderly

The effect of Zinc Supplementation on mood, anxiety and quality of life in the elderly of Kashan

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017071635110N1
Enrollment
150
Registered
2017-08-01
Start date
2017-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Mood (depression). Condition 2: Anxiety. Condition 3: Quality of life. Mood [affective] disorders Organic anxiety disorder Lifestyle-related condition

Interventions

Intervention 1: In the control group: No action is taken. Intervention 2: In the intervention group: Zinc supplemented pill is a zinc gluconate form and it contains 30 mg zinc for 70 days will be give
Treatment - Drugs

Sponsors

Vice chancellor for research - Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for this study are: having full satisfaction to participate in this study; seniors 60 years and older; Iranian citizenship; the ability to speak Farsi and answer questions; not using Zinc Supplement; no cognitive impairment (for the elderly with literacy based on the MMSE questionnaire score 25 and more and for the illiterate elderly, based on the AMTS questionnaire, score 7 and more); lack of liver and intestinal diseases as well as the absence of known cases of depression and anxiety both of these are diagnosed by the doctor. People with serum zinc levels in them based on experiment within be normal range; in that sense people whose serum zinc level is higher or lower than normal range do not enter the study.The exclusion criteria for this study are: the lack of cooperation and refusal of the elderly to continue to participate in research; the consumption of zinc supplement in the control group during the course of 70 days of intervention; the occurrence of severe stress, such as hospitalization or death of relatives in both groups during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mood(depression). Timepoint: Before the intervention and 70 days after the intervention began. Method of measurement: GDS standard questionnaire.;Anxiety. Timepoint: Before the intervention and 70 days after the intervention began. Method of measurement: BAI standard questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: Before the intervention and 70 days after the intervention began. Method of measurement: SF-36 standard questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Afzali

Shahroud University of Medical Sciences

Afzali.a1373@shmu.ac.ir+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026